Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|Breast Cancer
Interventions: OTHER: non interventional study
Sponsor: Assistance Publique - Hôpitaux de Paris